Opexa Therapeutics Inc. (Nasdaq: OPXA) reported positive results for its vaccine treatment of multiple sclerosis sending the stock price soaring $3.57 to $5.10.
Opexa Reports Positive Test Results
September 08, 2009 at 13:11 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.